Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room
Recruiting now · Phase 3
Conditions studied: Rapid Sequence Induction
In brief
The best hypnotic choice to optimize the balance between good intubation condition quality and hemodynamic stability during RSI performed in the operating theatre remained to be investigated. Therefore, a randomized study evaluating the efficacy of propofol, ketamine, and a combination of both is appropriate. So, we designed the HyPnotiKs randomized controlled study to investigate the efficacy of these hypnotic drugs in patients undergoing RSI in the operating theatre. The primary endpoint will be the successful tracheal intubation at the first attempt without major arterial hypotension event.
Key facts
- Study ID
- NCT06733129
- Run by
- Nantes University Hospital
- People needed
- 1218
- Starts
- 2025-04-14
- Expected to finish
- 2027-04-30
- Last updated by the study team
- 2025-12-02
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- age between 18 - 80 years' old
- female* and male
- ≥ 1 risk factor of aspiration of gastric contents defined as
- preoperative fasting period of less than 6 hours,
- occlusive syndrome, functional ileus, vomiting episode within the last 12 hours,
- orthopaedic trauma within the last 12 hours,
- medical history of symptomatic gastroesophageal reflux or hiatus, hernia or gastroparesis or dysautonomia or gastroesophageal surgery with sphincter dysfunction)
- patient requiring orotracheal intubation during general anaesthesia in the operating room.
- patient or his/her next of kin written informed consent or emergency procedure
- failure to discontinue GLP1 analogue as recommended (exenatide, liraglutide, albiglutide, taspoglutide, lixisenatide)
You may not qualify if…
- predicted impossible tracheal intubation (≥ 1 of the following criteria: patient with known intubation complications, Mallampati score IV, Thyromental Distance ≤ 4.0 cm, Mouth Opening < 3 cm, Sternomental Distance < 12.5 cm, significant modification of the airway due to congenital, cancer, trauma or burning lesions (non-exhaustive list)) [30]
- preoperative arterial hypotension (MAP < 65 mmHg or under catecholamine)
- preoperative respiratory distress syndrome (SpO2 < 90% in room air)
- contraindications to the use of ketamine and/or propofol and/or NMB:
- allergy to the active substance or to one of the excipients or to soy or peanuts,
- porphyria
- intracranial hypertension
- uncontrolled arterial hypertension (systolic arterial pressure > 180 mmHg)
- personal or family history of known malignant hyperthermia, congenital muscular dystrophy, myasthenia, a known congenital deficit in plasma pseudocholinesterase
- pregnancy or breast-feeding woman
- patients under court protection or guardianship
- absence of insurance covering health costs
Where it is running
- CHD Vendée — La Roche-sur-Yon, France (enrolling)
- Chu Nantes (Laennec) — Nantes, France (enrolling)
- Chu Nantes — Nantes, France (enrolling)
- CHU Dijon — Dijon, France (enrolling)
- CH Le Mans — Le Mans, France (enrolling)
- CHU Poitiers — Poitiers, France (enrolling)
- Hopital Foch — Suresnes, France (enrolling)
- CHU Lille Hopital Salengro — Lille, France (enrolling)
- Chr Angers — Angers, France (enrolling)
- CHU Lille Hôpital Claude Huriez — Lille, France (enrolling)
- CHRU de Brest Hôpital Cavale Blanche — Brest, France (enrolling)
- CHU Toulouse Hôpital Rangueil — Toulouse, France
- Ch Louis Pasteur — Chartres, France
- CHU Grenoble Alpes — Grenoble, France
- APHP Bicêtre — Le Kremlin-Bicêtre, France
- CHU Lyon Hôpital Sud — Lyon, France
- HCL Lyon Croix-Rousse — Lyon, France
- APHP St-Antoine — Paris, France
- APHP Tenon — Paris, France
- CHU Toulouse Hôpital Purpan — Toulouse, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.